Skip to main content

Incyte to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:

  • Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 at 12:45 pm (EDT)



  • Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024 at 10:45 am (EDT)



  • Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 9:45 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.95
+1.20 (0.47%)
AAPL  354.74
+1.96 (0.55%)
AMD  504.59
+0.31 (0.06%)
BAC  49.99
-0.09 (-0.18%)
GOOG  280.31
-0.95 (-0.34%)
META  624.37
-2.04 (-0.33%)
MSFT  511.26
-6.73 (-1.30%)
NVDA  155.33
-0.81 (-0.52%)
ORCL  117.65
-1.44 (-1.21%)
TSLA  381.73
+1.99 (0.52%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.